Cemsidomide

Overview

Cemsidomide (CFT7455) is a ubiquitin ligase pathway based IKZF1/3 ( Ikaros / Aiolos ) degrader with molecular glue activity. Cemsidomide has a GI 50 of 0.05 nM for NCIH929.1 cells. Cemsidomide is used in the research of multiple myeloma (MM).

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > Molecular Glues | Products > Signaling Pathways > IKZF Family

Product Information

• Catalog No.: HY-144841
• CAS No.: 2504235-67-8
• Molecular Formula: C28H27N3O4
• Molecular Weight: 469.53
• Purity: 99.54%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (5.32 mM); Clear solution
• Availability: In-stock

Source

Original product source